Prescribing Process

The prescribing process is a systematic clinical reasoning framework that translates a confirmed diagnosis into a safe, effective, and monitored pharmacotherapeutic plan. It begins with establishing an accurate diagnosis — prescribing without diagnostic certainty leads to masking of serious conditions, therapeutic failure, and unnecessary adverse drug effects. Once the diagnosis is confirmed, the NP selects a drug class based on current clinical practice guidelines (ACC/AHA, ADA, GINA, IDSA) and then chooses a specific agent within that class based on pharmacodynamic principles (mechanism of action matching the pathophysiology), pharmacokinetic suitability (considering the patient's renal function via CKD-EPI eGFR, hepatic function via Child-Pugh classification, age-related changes in body composition and organ function), and patient-specific factors (allergies, comorbidities, pregnancy/lactation status, pharmacogenomic profile, concurrent medications, cost, and adherence barriers). Drug-drug interactions occur through multiple mechanisms: CYP450 enzyme inhibition (e.g., fluconazole inhibiting CYP2C9 and potentiating warfarin bleeding risk), enzyme induction (e.g., rifampin inducing CYP3A4 and reducing oral contraceptive efficacy), protein binding displacement (e.g., valproic acid displacing phenytoin from albumin, increasing free phenytoin and toxicity risk), pharmacodynamic interactions (e.g., additive QTc prolongation from combining fluoroquinolones with...